Phase II Study of Chemo-Radiotherapy in Patients With Resectable and Borderline Resectable Pancreatic Cancer

NCT02243358 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Pancreas Neoplasm Malignant Resectable

Interventions

DRUG: Folfox6
DRUG: Gemcitabine
RADIATION: Radiation Therapy
PROCEDURE: Pancreaticoduodenectomy with retroperitoneal lymphadenectomy

Sponsor

Henry Ford Health System